MNDA (myeloid cell nuclear differentiation antigen) is a PYHIN family protein that functions as a transcriptional regulator in leukocytes, playing critical roles in immune responses and cell death control 1. In myeloid cells, MNDA acts as a transcriptional activator/repressor during granulocyte and monocyte responses to interferon, while also regulating B cell functions through negative regulation of proliferation and involvement in B cell receptor signaling 1. Mechanistically, MNDA localizes primarily to the nucleus of myeloid and lymphoid leukocytes and directly controls transcription of genes encoding factors that regulate apoptosis and inflammation 1. Its subcellular localization is dynamically modulated in response to genotoxic agents and bacterial constituents, allowing rapid cellular responses to stress and infection 1. Clinically, MNDA expression abnormalities have significant implications for hematopoietic diseases characterized by defective apoptosis regulation, where MNDA serves as both a lymphoma marker and prognostic factor 1. Abnormal MNDA expression associates with altered cytokine and inflammatory mediator levels, suggesting its involvement in dysregulated immune responses 1. Understanding MNDA's regulatory mechanisms and molecular functions could substantially influence management and treatment strategies for hematologic and inflammatory diseases.